Salarius Pharmaceuticals (SLRX) Short Interest Ratio & Short Volume $1.37 -0.09 (-6.16%) (As of 11/22/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Salarius Pharmaceuticals Short Interest DataSalarius Pharmaceuticals (SLRX) has a short interest of 65,000 shares, representing 4.64% of the float (the number of shares available for trading by the public). This marks a 4,233.33% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 45,546 shares to cover all short positions.Current Short Interest65,000 sharesPrevious Short Interest1,500 sharesChange Vs. Previous Month+4,233.33%Dollar Volume Sold Short$104,650.00Short Interest Ratio0.2 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares1,440,000 sharesFloat Size1,400,000 sharesShort Percent of Float4.64%Today's Trading Volume16,922 sharesAverage Trading Volume45,546 sharesToday's Volume Vs. Average37% Short Selling Salarius Pharmaceuticals? Sign up to receive the latest short interest report for Salarius Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSLRX Short Interest Over TimeSLRX Days to Cover Over TimeSLRX Percentage of Float Shorted Over Time Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Salarius Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202465,000 shares $104,650.00 +4,233.3%4.6%0.2 $1.61 10/15/20241,500 shares $2,280.00 -90.0%0.1%0 $1.52 9/30/202415,000 shares $21,600.00 +59.6%1.1%0 $1.44 9/15/20249,400 shares $14,664.00 -38.6%0.7%0 $1.56 8/31/202415,300 shares $25,398.00 -64.0%1.1%0 $1.66 8/15/202442,500 shares $85,425.00 -50.8%3.2%0 $2.01 Get the Latest News and Ratings for SLRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Salarius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/31/202486,300 shares $220,928.00 +44.1%15.4%0 $2.56 7/15/202459,900 shares $106,622.00 +215.3%10.7%0 $1.78 6/30/202419,000 shares $45,220.00 +375.0%27.1%0.9 $2.38 6/15/20244,000 shares $13,526.40 -85.4%5.7%0.2 $3.38 5/31/202427,300 shares $12,645.36 -18.5%0.6%0.2 $0.46 5/15/202433,500 shares $15,343.00 -54.5%0.8%0.3 $0.46 4/30/202473,600 shares $36,726.40 -36.3%1.7%0.6 $0.50 4/15/2024115,600 shares $57,800.00 -57.0%2.6%1 $0.50 3/31/2024268,900 shares $142,140.54 +1,767.4%6.7%2.4 $0.53 3/15/202414,400 shares $9,360.00 -20.0%0.4%0.1 $0.65 2/29/202418,000 shares $12,060.00 +227.3%0.5%0.6 $0.67 2/15/20245,500 shares $3,245.00 -33.7%0.2%0.2 $0.59 1/31/20248,300 shares $4,556.70 +36.1%0.2%0.2 $0.55 1/15/20246,100 shares $3,721.00 -37.1%0.2%0.2 $0.61 12/31/20239,700 shares $6,305.00 +38.6%0.3%0.3 $0.65 12/15/20237,000 shares $4,515.00 -71.9%0.2%0.1 $0.65 11/30/202324,900 shares $17,679.00 -56.0%0.7%0.4 $0.71 11/15/202356,600 shares $40,752.00 -22.7%1.6%1.1 $0.72 10/31/202373,200 shares $61,334.28 +136.9%2.3%1.2 $0.84 10/15/202330,900 shares $21,321.00 +62.6%0.9%0.5 $0.69 9/30/202319,000 shares $12,500.08 -6.4%0.6%0.3 $0.66 9/15/202320,300 shares $17,395.07 -26.5%0.6%0.4 $0.86 8/31/202327,600 shares $24,285.24 +162.9%0.8%0.5 $0.88 8/15/202310,500 shares $7,490.70 +54.4%0.3%0.2 $0.71 7/31/20236,800 shares $6,249.20 -60.9%0.2%0.1 $0.92 7/15/202317,400 shares $19,314.00 -44.8%0.6%0.2 $1.11 6/30/202331,500 shares $46,935.00 -41.2%1.0%0.3 $1.49 6/15/202353,600 shares $85,224.00 +9.6%1.7%0.5 $1.59 5/31/202348,900 shares $68,949.00 -48.4%2.1%0.5 $1.41 5/15/202394,700 shares $136,368.00 -16.1%4.2%1 $1.44 4/30/2023112,800 shares $200,784.00 -11.9%5.4%1.3 $1.78 4/15/2023128,000 shares $220,160.00 +6.1%6.1%2.5 $1.72 3/31/2023120,700 shares $230,537.00 -4.2%5.8%0.8 $1.91 3/15/2023126,000 shares $255,780.00 -4.0%6.6%0.7 $2.03JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. 2/28/2023131,300 shares $279,669.00 +16.7%6.8%0.7 $2.13 2/15/2023112,500 shares $252,000.00 +11.3%5.9%0.6 $2.24 1/31/2023101,100 shares $260,838.00 +37.7%5.2%0.6 $2.58 1/15/202373,400 shares $194,510.00 +272.6%3.8%0.4 $2.65 12/30/202219,700 shares $30,141.00 -46.6%1.0%0.3 $1.53 12/15/202236,900 shares $55,719.00 +93.2%1.9%0.8 $1.51 11/30/202219,100 shares $36,863.00 -12.0%1.0%0.4 $1.93 11/15/202221,700 shares $46,655.00 +100.9%1.1%0.5 $2.15 10/31/202210,800 shares $21,924.00 -31.2%0.5%0.3 $2.03 10/15/202215,700 shares $71,042.50 -95.8%0.8%0.4 $4.53 9/30/2022371,000 shares $72,345.00 -8.4%N/A0.9 $0.20 9/15/2022405,000 shares $95,904.00 +9.6%N/A0.8 $0.24 8/31/2022369,500 shares $74,269.50 -16.3%N/A0.7 $0.20 8/15/2022441,600 shares $99,360.00 +257.3%N/A0.7 $0.23 7/31/2022123,600 shares $23,508.72 +7.3%N/A0.1 $0.19 7/15/2022115,200 shares $21,876.48 -33.8%N/A0.1 $0.19 6/30/2022174,100 shares $36,561.00 -54.6%N/A0.1 $0.21 6/15/2022383,300 shares $77,733.24 -9.8%N/A0.3 $0.20 5/31/2022425,000 shares $76,627.50 -3.8%N/A0.4 $0.18 5/15/2022441,800 shares $83,014.22 -26.6%N/A0.4 $0.19 4/30/2022602,200 shares $121,644.40 +31.4%N/A1.1 $0.20 4/15/2022458,300 shares $163,658.93 -14.7%N/A1.1 $0.36 3/31/2022537,100 shares $213,819.51 +11.7%N/A1.3 $0.40 3/15/2022480,900 shares $165,429.60 -23.8%N/A1 $0.34 2/28/2022630,900 shares $252,423.09 +0.4%N/A1.8 $0.40 2/15/2022628,200 shares $285,831.00 -3.7%N/A1.7 $0.46 1/31/2022652,400 shares $293,580.00 -2.0%4.5%1.5 $0.45 1/15/2022665,600 shares $312,832.00 +4.2%4.6%1.4 $0.47 12/31/2021638,500 shares $316,440.60 -7.3%4.4%1.3 $0.50 12/15/2021688,600 shares $365,853.18 -35.0%4.7%1.4 $0.53 11/30/20211,060,000 shares $689,000.00 +1.0%7.3%1.5 $0.65 11/15/20211,050,000 shares $796,950.00 +7.5%7.2%1.1 $0.76 10/29/2021976,600 shares $808,331.82 -0.2%6.7%0.8 $0.83 10/15/2021978,900 shares $886,002.39 -24.1%6.7%0.8 $0.91 9/30/20211,290,000 shares $1.32 million -4.4%8.9%1 $1.02 9/15/20211,350,000 shares $1.39 million -2.9%9.3%1 $1.03 8/31/20211,390,000 shares $1.45 million +9.5%9.6%1 $1.04 8/13/20211,270,000 shares $1.17 million -8.0%8.8%0.7 $0.92 7/30/20211,380,000 shares $1.12 million -9.2%9.5%0.8 $0.81 7/15/20211,520,000 shares $1.38 million -19.2%10.5%0.9 $0.91 6/30/20211,880,000 shares $1.99 million +0.5%13.0%1.1 $1.06 6/15/20211,870,000 shares $2.24 million +14.7%12.9%1.1 $1.20 5/28/20211,630,000 shares $2.09 million -2.4%11.3%1 $1.28 5/14/20211,670,000 shares $2.04 million +29.5%N/A1.3 $1.22 4/30/20211,290,000 shares $1.72 million -5.8%N/A0.6 $1.33 4/15/20211,370,000 shares $1.78 million -12.7%N/A0.6 $1.30 3/31/20211,570,000 shares $2.25 million +41.4%N/A0.6 $1.43 3/15/20211,110,000 shares $1.81 million -41.6%N/A0.4 $1.63 2/26/20211,900,000 shares $3.67 million +15.2%N/A0.7 $1.93 2/12/20211,650,000 shares $4.36 million +202.6%N/A0.6 $2.64JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. 1/29/2021545,200 shares $594,268.00 -11.3%N/A0.3 $1.09 1/15/2021614,300 shares $712,588.00 +7.3%N/A0.6 $1.16 12/31/2020572,800 shares $510,937.60 +22.8%N/A0.7 $0.89 12/15/2020466,600 shares $407,295.14 -2.1%N/A0.8 $0.87 11/30/2020476,400 shares $325,857.60 -18.6%N/A1.1 $0.68 11/15/2020585,000 shares $427,050.00 +3.0%N/A3.9 $0.73 10/30/2020568,000 shares $382,434.40 -11.4%N/A3.6 $0.67 10/15/2020640,800 shares $583,128.00 -5.2%N/A2.8 $0.91 9/30/2020675,900 shares $570,392.01 +22.7%N/A2.9 $0.84 9/15/2020551,100 shares $506,736.45 -4.2%N/A2.2 $0.92 8/31/2020575,000 shares $540,500.00 +1.4%N/A1.6 $0.94 8/14/2020567,000 shares $569,835.00 -40.8%N/A1 $1.01 7/31/2020958,000 shares $1.10 million +3.7%N/A1.4 $1.15 7/15/2020924,200 shares $1.22 million -6.1%N/A1.3 $1.32 6/30/2020984,200 shares $1.30 million +0.6%N/A1.4 $1.32 6/15/2020978,400 shares $1.50 million +48.5%N/A1.4 $1.53 5/29/2020659,000 shares $691,950.00 +120.0%N/A1.1 $1.05 5/15/2020299,600 shares $254,689.96 +14.5%N/A0.7 $0.85 4/30/2020261,700 shares $217,237.17 +38.0%N/A0.6 $0.83 4/15/2020189,600 shares $117,589.92 +83.5%N/A0.6 $0.62 3/31/2020103,300 shares $65,079.00 +37.4%N/A0.4 $0.63 3/13/202075,200 shares $51,888.00 +89.4%N/A0.3 $0.69 2/28/202039,700 shares $24,614.00 +146.6%N/A0.1 $0.62 2/14/202016,100 shares $12,558.00 -89.4%0.5%0.1 $0.78 1/31/2020151,700 shares $131,979.00 +89.9%4.8%0.9 $0.87 1/15/202079,900 shares $67,116.00 -24.4%2.5%1.2 $0.84 12/31/2019105,700 shares $288,561.00 +101.7%3.7%1.8 $2.73 SLRX Short Interest - Frequently Asked Questions What is Salarius Pharmaceuticals' current short interest? Short interest is the volume of Salarius Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 65,000 shares of SLRX short. 4.64% of Salarius Pharmaceuticals' shares are currently sold short. Learn More on Salarius Pharmaceuticals' current short interest. What is a good short interest percentage for Salarius Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.64% of Salarius Pharmaceuticals' floating shares are currently sold short. Is Salarius Pharmaceuticals' short interest increasing or decreasing? Salarius Pharmaceuticals saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 65,000 shares, an increase of 4,233.3% from the previous total of 1,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Salarius Pharmaceuticals' float size? Salarius Pharmaceuticals currently has issued a total of 1,440,000 shares. Some of Salarius Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Salarius Pharmaceuticals currently has a public float of 1,400,000 shares. How does Salarius Pharmaceuticals' short interest compare to its competitors? 4.64% of Salarius Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Salarius Pharmaceuticals: Sonoma Pharmaceuticals, Inc. (4.14%), Ensysce Biosciences, Inc. (43.43%), Alterity Therapeutics Limited (0.04%), Coeptis Therapeutics Holdings, Inc. (0.52%), Galecto, Inc. (0.42%), Biora Therapeutics, Inc. (4.76%), Syros Pharmaceuticals, Inc. (6.35%), ABVC BioPharma, Inc. (1.77%), Brainstorm Cell Therapeutics Inc. (2.27%), Edesa Biotech, Inc. (0.75%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Salarius Pharmaceuticals stock? Short selling SLRX is an investing strategy that aims to generate trading profit from Salarius Pharmaceuticals as its price is falling. SLRX shares are trading down $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Salarius Pharmaceuticals? A short squeeze for Salarius Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SLRX, which in turn drives the price of the stock up even further. How often is Salarius Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SLRX, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies SNOA Short Interest ENSC Short Interest ATHE Short Interest COEP Short Interest GLTO Short Interest BIOR Short Interest SYRS Short Interest ABVC Short Interest BCLI Short Interest EDSA Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SLRX) was last updated on 11/24/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | Sponsored#1 Crypto of 2024Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Salarius Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Salarius Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SLRX Stock Alerts